Please use this identifier to cite or link to this item:
|Title:||Prostaglandin synthetase inhibition reduces peritonitis-induced early liver oxidant stress|
|Authors:||Uludağ Üniversitesi/Tıp Fakültesi/Cerrahi Anabilim Dalı.|
Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı.
Gür, Esma Sürmen
|Citation:||Tokyay, R. vd. (1999). "Prostaglandin synthetase inhibition reduces peritonitis-induced early liver oxidant stress". Surgery Today - The Japanese Journal of Surgery, 29(1), 42-46.|
|Abstract:||This study was undertaken to determine whether or not the prostanoid metabolism contributes to peritonitis-induced early liver oxidant stress, Lipid peroxidation products, malondialdehyde (MDA) and conjugated dienes (CD), were used to monitor oxidant stress, The rats mere given a 5-cc intraperitoneal (i.p.) injection of 25% rat feces suspension and then received either i.p. saline (peritonitis group, n = 11), vitamin E (n = 6), or diclofenac (n = 6), The liver and plasma MDA and CD levels n ere measured after Sh, The plasma and liver AIDA and CD levels mere significantly higher in the peritonitis group than in the control (n = 9), Prostaglandin synthetase inhibitor (diclofenac) kept the liver and plasma MDA and CD at control levels. Antioxidant alpha tacopherol (vitamin E) was thus found not to be effective in reducing these increased MDA and CD levels. Peritonitis-induced early oxidant stress in the liver seems to be mediated by the oxidant-independent activation of the cyclooxygenase pathway.|
|Appears in Collections:||Scopus|
Web of Science
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.